Recent Progress in Mind-Body Therapies in Cancer Care.


Journal

Current oncology reports
ISSN: 1534-6269
Titre abrégé: Curr Oncol Rep
Pays: United States
ID NLM: 100888967

Informations de publication

Date de publication:
04 2023
Historique:
accepted: 18 11 2022
medline: 5 4 2023
pubmed: 9 2 2023
entrez: 8 2 2023
Statut: ppublish

Résumé

Mind-body therapies (MBTs) are integrative medicine modalities that continue to grow in popularity among people with cancer. MBTs are used to enhance well-being and most commonly include relaxation and imagery, hypnosis, yoga, meditation, Tai Chi and Qigong, and creative therapies. Biofield and psychedelic-assisted therapies are also gaining momentum as MBTs. Herein, recent literature was narratively reviewed to summarize the effectiveness of these MBTs within the context of cancer care. There is growing evidence for the effectiveness of MBTs for addressing a myriad of physical (e.g., pain) and psychosocial (e.g., depression, fatigue) symptoms and biomarkers of stress and immune function in people with cancer. Psychedelic-assisted therapies have robust, sustained effects on symptoms of depression, anxiety, and distress in small clinical trials to date. However, across modalities, MBT studies continue to struggle with methodological issues such as intervention standardization, facilitator training, small sample sizes, and short follow-up. Accumulating evidence supports the use of MBTs for people with cancer. Future research should work to address methodological issues and focus on creating knowledge translation tools; these can be leveraged to better educate health care providers and patients regarding evidence-based MBT options to support patients in making informed decisions about their health.

Identifiants

pubmed: 36753025
doi: 10.1007/s11912-023-01373-w
pii: 10.1007/s11912-023-01373-w
doi:

Substances chimiques

Hallucinogens 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-307

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Julie M Deleemans (JM)

Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Haley Mather (H)

Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Athina Spiropoulos (A)

Department of Psychology, University of Calgary, Calgary, Canada.

Kirsti Toivonen (K)

Department of Adult Mental Health, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Canada.

Mohamad Baydoun (M)

Faculty of Nursing, University of Regina, Regina, Canada.

Linda E Carlson (LE)

Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. l.carlson@ucalgary.ca.
Department of Psychosocial Oncology, Cancer Control Alberta: Holy Cross Site, 2202 2nd St. SW, Calgary, AB, T2S 3C1, Canada. l.carlson@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH